Literature DB >> 3391523

Fragmentation of gallstones using extracorporeal shock waves: an in vitro study.

R Schachler1, T Sauerbruch, U Wosiewitz, J Holl, D Hahn, R Denk, M Neubrand, G Paumgartner.   

Abstract

Eighty in vitro experiments were performed with single (n = 51) or multiple (n = 29) gallstones in order to find out which parameters are of prime importance for their disintegration by extracorporeal shock waves. A Dornier lithotripter and an upper limit of 1,500 discharges were employed. Although computed tomography density was significantly lower in cholesterol stones than in the noncholesterol stones (p less than 0.0001) and although the latter were significantly more often radiopaque (p less than 0.0001), we found no clear-cut correlation between the cholesterol content or computed tomography density and the degree of fragmentation of the stones. The most important variable which limited successful disintegration was the total stone volume. In stones with a mean total volume of 0.83 ml +/- 0.25 S.E. (diameter for single stones = 11.5 +/- 0.9 mm), none of the fragments exceeded 2 mm, whereas in stones with a mean volume of 3.6 ml +/- 0.64 (diameter = 17.2 +/- 1.5 mm) at least one fragment larger than 2 mm remained (p less than 0.002). Under the in vitro conditions, fragmentation was similar in multiple and solitary stones, provided the volume of the stones was comparable. These data show that, in general, the number and size of the stones, i.e. their total volume, and much less significantly their chemical composition are the major determinants of fragmentation by extracorporeal shock waves.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3391523     DOI: 10.1002/hep.1840080437

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  11 in total

Review 1.  Biliary extracorporeal shockwave lithotripsy.

Authors:  B Rawat; H J Burhenne
Journal:  Cardiovasc Intervent Radiol       Date:  1990 Aug-Sep       Impact factor: 2.740

Review 2.  Extracorporeal biliary lithotripsy and direct chemolitholysis-an integrated concept.

Authors:  W Domschke
Journal:  Gastroenterol Jpn       Date:  1989-10

3.  In vitro study to elucidate the physical laws concerning the fragmentation of both solitary and multiple artificial stones.

Authors:  H Lobentanzer; M Neubrand; H Hermeking; T Sauerbruch
Journal:  Clin Investig       Date:  1993-11

4.  Extracorporeal shock wave lithotripsy of gall stones: an in vitro comparison between an electrohydraulic and a piezoceramic device.

Authors:  R Schachler; N C Bird; T Sauerbruch; E A Frost; M Sackmann; G Paumgartner; A G Johnson
Journal:  Gut       Date:  1991-03       Impact factor: 23.059

5.  In vivo analysis of gallstone composition by computed tomography.

Authors:  J G Bova; W H Schwesinger; W E Kurtin
Journal:  Gastrointest Radiol       Date:  1992

6.  Computed tomography in predicting gall stone solubility: a prospective trial.

Authors:  A Caroli; G Del Favero; F Di Mario; F Spigariol; P Scalon; T Meggiato; C Zambelli; R Naccarato
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

7.  Biliary stones: treatment by shock-wave lithotripsy.

Authors:  M Sackmann; T Sauerbruch; M Delius; J Holl; W Brendel; G Paumgartner
Journal:  Surg Endosc       Date:  1988       Impact factor: 4.584

8.  Pulverisation of calcified and non-calcified gall bladder stones: extracorporeal shock wave lithotripsy used alone.

Authors:  N Soehendra; V C Nam; K F Binmoeller; H Koch; S Bohnacker; H W Schreiber
Journal:  Gut       Date:  1994-03       Impact factor: 23.059

9.  Extracorporeal shock-wave lithotripsy prior to laparoscopic cholecystectomy. Does it make sense?

Authors:  V Lange; G Meyer; H M Schardey; M Neubrandt; U Klüppelberg
Journal:  Surg Endosc       Date:  1994-11       Impact factor: 4.584

10.  Effect of laser fragmentation of cholesterol and mixed gallstones on in vitro dissolution in methyl tert-butyl ether.

Authors:  B F Smith
Journal:  Dig Dis Sci       Date:  1990-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.